Novartis AG

Introduction
Novartis AG is a global healthcare and pharmaceutical company headquartered in Switzerland. Established in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis is one of the world’s largest pharmaceutical companies. The company focuses on developing innovative medicines, advanced therapies, and generics to improve health outcomes across the globe.

Mission and Vision

Mission: To reimagine medicine to improve and extend people’s lives.
Vision: To be the most respected and trusted medicines company in the world, bringing transformative treatments to patients everywhere.

Products and Services

Innovative Medicines: Treatments for oncology, cardiology, immunology, neuroscience, and ophthalmology.
Cell & Gene Therapies: Cutting-edge therapies including CAR-T treatments for cancer.
Sandoz (Generics & Biosimilars): Providing affordable, high-quality generics and biosimilars worldwide (spun off in 2023 as an independent company).
Ophthalmology: Treatments for eye diseases such as macular degeneration.
Research and Development: Strong focus on advanced drug discovery and biotechnology.

Growth and Innovation
Novartis is recognized for pioneering work in cell and gene therapy, including its CAR-T therapy Kymriah, which revolutionized treatment for certain blood cancers. The company has also been at the forefront of digital transformation in healthcare, leveraging AI and data science for drug discovery and clinical trials.

Global Impact
With operations in over 150 countries, Novartis has a significant impact on global healthcare. The company provides medicines that reach hundreds of millions of patients annually. Novartis is also committed to sustainability, equitable access to healthcare, and corporate responsibility initiatives aimed at underserved communities worldwide